jradler
New Member
- Joined
- Aug 3, 2025
- Messages
- 1
- Reaction score
- 0
Hi DNF Members,
Looking for appraisals on two .com domains I own. Both are aligned with major growth in biotech and digital health — backed by regulatory milestones, active patent filings, and billions in enterprise investment.
---
1. genomedigitaltwin.com
Market Validation
Combines two high-growth sectors: genomics and digital twin modeling
Applications in AI-based clinical trials, genome simulations, individualized therapies
NIH INCLUDE Project funding genomic digital twins for Down syndrome
DARPA Biological Technologies Office investing $65M+ in predictive bio platforms
NASA applying genomic twins to astronaut health research
FDA Breakthrough Device Program has cleared multiple genomic AI tools (2024–2025)
Enterprise Adoption
Microsoft Azure Genomics expanding digital twin systems
NVIDIA Clara building genome-scale simulation platforms
Tempus (valued $8.1B) developing personalized medicine twins
Buyer Targets
Illumina, Tempus, Deep Genomics, G42, Unlearn.AI, NVIDIA, GE HealthCare, Microsoft Genomics, 23andMe, Foundation Medicine
Use Cases
Genomic software platforms
AI drug discovery tools
Predictive patient modeling
Clinical trial optimization
---
2. heartdigitaltwin.com
FDA Precedent
inHeart cleared via 510(k) for an AI-driven digital twin of the heart (2024)
HeartFlow FFRCT FDA-cleared for coronary flow modeling
Siemens Healthineers released commercial digital heart twin platform
Applications in pre-op planning, AI cardiology, and device integration
Research & IP Landscape
NIH NHLBI: $45M+ in cardiac twin grants
FDA Innovation Pathway supporting cardiac digital tools
Patents cover:
Real-time heart modeling
Hemodynamic flow simulation
Arrhythmia prediction
Surgical digital planning systems
Adoption Momentum
Mayo Clinic and Cleveland Clinic launching digital heart trials
Buyer Targets
Medtronic, Philips, Siemens Healthineers, GE HealthCare, HeartFlow, Artrya, Abbott, Boston Scientific
---
Market Intelligence
SectorProjected Size (2030)CAGR
Digital Twin Healthcare$3.55B25.9%
Genomics Market$83B+15.5%
Cardiac Device Market$50B+Growing fast
> Bonus Insight: Take a quick look at digitaltwin.com — see what you discover.
---
Recent Validation:
Atomwise raised $123M for AI drug discovery (uses genomic modeling)
"Digital twin" appears 847+ times in FDA documentation (2024)
Major healthtech companies actively integrating digital twin infrastructure
---
Would love your honest feedback — including thoughts on:
End-user value
Wholesale reseller pricing
Strategic market fit
Thanks in advance for your insights!
Looking for appraisals on two .com domains I own. Both are aligned with major growth in biotech and digital health — backed by regulatory milestones, active patent filings, and billions in enterprise investment.
---
1. genomedigitaltwin.com
Market Validation
Combines two high-growth sectors: genomics and digital twin modeling
Applications in AI-based clinical trials, genome simulations, individualized therapies
NIH INCLUDE Project funding genomic digital twins for Down syndrome
DARPA Biological Technologies Office investing $65M+ in predictive bio platforms
NASA applying genomic twins to astronaut health research
FDA Breakthrough Device Program has cleared multiple genomic AI tools (2024–2025)
Enterprise Adoption
Microsoft Azure Genomics expanding digital twin systems
NVIDIA Clara building genome-scale simulation platforms
Tempus (valued $8.1B) developing personalized medicine twins
Buyer Targets
Illumina, Tempus, Deep Genomics, G42, Unlearn.AI, NVIDIA, GE HealthCare, Microsoft Genomics, 23andMe, Foundation Medicine
Use Cases
Genomic software platforms
AI drug discovery tools
Predictive patient modeling
Clinical trial optimization
---
2. heartdigitaltwin.com
FDA Precedent
inHeart cleared via 510(k) for an AI-driven digital twin of the heart (2024)
HeartFlow FFRCT FDA-cleared for coronary flow modeling
Siemens Healthineers released commercial digital heart twin platform
Applications in pre-op planning, AI cardiology, and device integration
Research & IP Landscape
NIH NHLBI: $45M+ in cardiac twin grants
FDA Innovation Pathway supporting cardiac digital tools
Patents cover:
Real-time heart modeling
Hemodynamic flow simulation
Arrhythmia prediction
Surgical digital planning systems
Adoption Momentum
Mayo Clinic and Cleveland Clinic launching digital heart trials
Buyer Targets
Medtronic, Philips, Siemens Healthineers, GE HealthCare, HeartFlow, Artrya, Abbott, Boston Scientific
---
Market Intelligence
SectorProjected Size (2030)CAGR
Digital Twin Healthcare$3.55B25.9%
Genomics Market$83B+15.5%
Cardiac Device Market$50B+Growing fast
> Bonus Insight: Take a quick look at digitaltwin.com — see what you discover.
---
Recent Validation:
Atomwise raised $123M for AI drug discovery (uses genomic modeling)
"Digital twin" appears 847+ times in FDA documentation (2024)
Major healthtech companies actively integrating digital twin infrastructure
---
Would love your honest feedback — including thoughts on:
End-user value
Wholesale reseller pricing
Strategic market fit
Thanks in advance for your insights!
